A panel of experts advising the Centers for Disease Control and Prevention is discussing rare blood clots that health officials have investigated in Johnson & Johnson coronavirus vaccine recipients.
A panel of experts advising the Centers for Disease Control and Prevention is discussing rare blood clots that health officials have investigated in Johnson & Johnson coronavirus vaccine recipients.